Percutaneous closure of perimembranous @entity1757 associated with septal XXXX in adults.

@entity1 @entity439 @entity1757
OBJECTIVE: Percutaneous closure of perimembranous @entity1757 (pmVSD) has become an accepted alternative to surgical closure in selected cases. However, closure of pmVSDs associated with septal @entity439 is more challenging. We report our experience of device closure of pmVSDs associated with septal @entity439 . METHODS: Between 2008 and 2012, percutaneous closure of pmVSD associated with septal @entity439 was attempted in 11 adult @entity1 in our institution. The @entity1 were followed up at 1, 3, 6, and 12 months after the procedure. RESULTS: Mean age of the @entity1 (64% male, 36% female) was 36.2  1.3 years. Diameter of the left and right ventricular openings of the @entity439 measured by ventriculography was 13.5  5.6 mm and 5.9  2.2 mm, respectively. The defect was occluded with Amplatzer pmVSD Occluder in 4 @entity1 , Amplatzer Muscular Ventricular Septal Defect Occluder in 4 @entity1 , Amplatzer Duct Occluder I in 1 @entity1 , and Amplatzer Duct Occluder II in 2 @entity1 (AGA Medical Corp., Plymouth, MN, USA). The procedure was succesfull in all @entity1 . Mean follow-up time was 22  1.9 months. There was no device- or procedure-related complications at the acute setting or mid-term follow-up. CONCLUSION: Percutaneous closure of pmVSDs associated with @entity439 is more challenging than that of simple defects. The selection of the device type and size should be made according to the configuration and size of the @entity439 and defect.
